- Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure
-
Jeong HY, Ko EJ, Kim SH, Lee MJ, Cho HJ, Yang DH, Lee SY
- KMID: 2419086
- Yonsei Med J.
- 2017 Jul;58(4):793-799.
- doi: 10.3349/ymj.2017.58.4.793
PURPOSE: Investigating the risk of vascular access failure is critical for maintenance hemodialysis (MHD) patients. Erythropoietin stimulating agents (ESA) typically used for anemia of chronic kidney disease (CKD) may also... -
- CITED
-
- Close
- SHARE
-
- Close
